经皮星状神经节阻滞治疗电风暴:STAR研究
STAR研究为多中心前瞻性观察研究,纳入2017年7月至2023年6月标准治疗无效的电风暴患者131例,共行184次经皮星状神经节阻滞(PSGB)。主要终点为PSGB后12小时较前12小时治疗性心律失常事件减少至少50%,92%患者达到;心律失常事件中位减少100%,严重并发症发生率0.5%。
要点
- PSGB可显著减少难治性电风暴患者的心律失常事件。
- 92%患者达到主要终点,心律失常事件中位减少100%。
- 严重并发症发生率低(0.5%),安全性可接受。
核心结论
- 这项大型前瞻性多中心研究支持PSGB治疗难治性电风暴的有效性和安全性。
研究设计与样本
- 多中心观察性研究,纳入2017年7月1日至2023年6月30日标准治疗无效的电风暴患者。
- 共纳入来自19个中心的131例患者,接受184次PSGB。
- 操作者接受前入路解剖法和侧入路超声引导法培训。
主要发现
- 主要终点(PSGB后12小时较前12小时治疗性心律失常事件减少至少50%)在92%患者中达到。
- PSGB前后12小时心律失常事件中位减少100%(四分位距-100%至-92.3%)。
- 发生1例严重并发症(0.5%)。
临床怎么用
- 对于标准治疗无效的电风暴患者,可考虑采用PSGB作为辅助治疗手段。
- 操作者应接受前入路解剖法和侧入路超声引导法培训。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: An electrical storm (ES) is a clinical emergency with a paucity of established treatment options. Despite initial encouraging reports about the safety and effectiveness of percutaneous stellate ganglion block (PSGB), many questions remained unsettled and evidence from a prospective multicentre study was still lacking. For these purposes, the STAR study was designed. METHODS: This is a multicentre observational study enrolling patients suffering from an ES refractory to standard treatment from 1 July 2017 to 30 June 2023. The primary outcome was the reduction of treated arrhythmic events by at least 50% comparing the 12 h following PSGB with the 12 h before the procedure. STAR operators were specifically trained to both the anterior anatomical and the lateral ultrasound-guided approach. RESULTS: A total of 131 patients from 19 centres were enrolled and underwent 184 PSGBs. Patients were mainly male (83.2%) with a median age of 68 (63.8-69.2) years and a depressed left ventricular ejection fraction (25.0 ± 12.3%). The primary outcome was reached in 92% of patients, and the median reduction of arrhythmic episodes between 12 h before and after PSGB was 100% (interquartile range -100% to -92.3%). Arrhythmic episodes requiring treatment were significantly reduced comparing 12 h before the first PSGB with 12 h after the last procedure [six (3-15.8) vs. 0 (0-1), P < .0001] and comparing 1 h before with 1 h after each procedure [2 (0-6) vs. 0 (0-0), P < .001]. One major complication occurred (0.5%). CONCLUSIONS: The findings of this large, prospective, multicentre study provide evidence in favour of the effectiveness and safety of PSGB for the treatment of refractory ES.
引用
- Savastano S, Baldi E, Compagnoni S, et al. Electrical storm treatment by percutaneous stellate ganglion block: the STAR study. Eur Heart J. 2024. PMID: 38289867. doi:10.1093/eurheartj/ehae021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。